Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-131818
Filing Date
2016-07-06
Accepted
2016-07-06 17:51:08
Documents
2
Period of Report
2016-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2838
2 POA DOCUMENT poa.txt EX-24.3_665957 2249
  Complete submission text file 0001209191-16-131818.txt   6587
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Issuer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HUDSON EXECUTIVE CAPITAL LP 1185 AVENUE OF THE AMERICAS, 32ND FL NEW YORK NY 10036
Business Address
Braunstein Douglas L (Reporting) CIK: 0001495110 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36306 | Film No.: 161754904